May 2, 2020

Hope Biosciences gets FDA nod for phase 2 COVID-19 stem cell therapy trial

Posted by in category: biotech/medical

Hope Biosciences has been given clearance from the US Food and Drug Administration (FDA) to move ahead with a phase 2 trial to evaluate its investigational stem cell therapy in providing immune support against COVID-19.

Comments are closed.